COMPANY

Adjuvia Therapeutics

HQ: San Francisco, CA source · adjuvia.com ↗ · West Coast

Location: San Francisco, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Friedreich Ataxia Cardiomyopathies Central Nervous System Diseases Neuromuscular Diseases Mitochondrial Diseases Mitochondrial Dysfunction Genetic Disease ATI-105

1Trials (company is sponsor)

Timeline

Oct 26, 2026 Trial start Phase 1: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults source ↗

Upcoming milestones

May 27, 2027 (ESTIMATED) · Phase 1 · A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults · NCT07869654

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07869654	A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults	Phase 1	Not yet recruiting	Oct 26, 2026	May 27, 2027 (estimated)